Another Potential Benefit of Neoadjuvant Therapy in Pancreatic Cancer: Reduction in Postoperative Readmission Rates Mashaal DhirChandrakanth Are Global Health Services Research 02 January 2021 Pages: 1871 - 1873
A Tool for Patient-Focused Care Regarding Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma Katherine S. CoolsEvan S. Glazer Hepatobiliary Tumors 08 January 2021 Pages: 1874 - 1875
TACE or TARE for Unresectable Neuroendocrine Liver Metastases: Can we Finally Start to Focus on Value? Charles R. Scoggins Hepatobiliary Tumors 28 January 2021 Pages: 1876 - 1877
Electronic Patient-Reported Outcomes After Thoracic Surgery: Toward Better Remote Management of Perioperative Symptoms Cecilia PompiliEthan BaschGita N. Mody Thoracic Oncology 21 January 2021 Pages: 1878 - 1879
Is It Time to Add Tumor Regression Grade into the ypN Category? Yin-Kai Chao Thoracic Oncology 03 January 2021 Pages: 1880 - 1881
Editorial Comment on: MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy Takehiko Yokobori Pancreatic Tumors 28 November 2020 Pages: 1882 - 1883
Multimodality Therapy in Operable Pancreatic Cancer: Should We Sequence Surgery Last? Jashodeep DattaNipun B. Merchant Pancreatic Tumors 16 January 2021 Pages: 1884 - 1886
ASO Editorial: Nodal Status as a Clinical Tool in the Treatment of Pancreatic Cancer Marianna V. PapageorgeTeviah E. Sachs Pancreatic Tumors 16 January 2021 Pages: 1887 - 1888
The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell Carcinoma Hanan Goldberg Urologic Oncology 08 February 2021 Pages: 1889 - 1891
Global Forum of Cancer Surgeons: Support for the Brazilian Society of Surgical Oncology Journey towards Implementation of Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy in Brazil Alexandre Ferreira OliveiraClaudio Almeida QuadrosChandrakanth Are Global Health Services Research 18 January 2021 Pages: 1892 - 1895
Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study Sivesh K. KamarajahSamer A. NaffoujeFadi S. Dahdaleh Global Health Services Research 04 January 2021 Pages: 1896 - 1905
ASO Author Reflections: Is Neoadjuvant Chemotherapy Associated with Acceptable Short-Term Outcomes for Pancreatic Cancer? Sivesh K. KamarajahFadi Dahdaleh ASO Author Reflections 02 January 2021 Pages: 1906 - 1907
Direct Comparison of In-Person Versus Virtual Interviews for Complex General Surgical Oncology Fellowship in the COVID-19 Era Monica M. GrovaSean J. DonohueDavid W. Ollila Health Services Research and Global Oncology 26 November 2020 Pages: 1908 - 1915
ASO Author Reflections: The Impact of Virtual Interviews for Complex General Surgical Oncology Fellowship Monica M. GrovaDavid W. Ollila ASO Author Reflections 07 January 2021 Pages: 1916 - 1917
Race/Ethnicity and County-Level Social Vulnerability Impact Hospice Utilization Among Patients Undergoing Cancer Surgery Alizeh AbbasJ. Madison HyerTimothy M. Pawlik Health Services Research and Global Oncology 14 October 2020 Pages: 1918 - 1926
ASO Author Reflections: How Does Social Vulnerability Impact Hospice Utilization Among Patients Undergoing Cancer Surgery? Alizeh AbbasTimothy M. Pawlik ASO Author Reflections 09 October 2020 Pages: 1927 - 1928
Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study Joshua P. KronenfeldEmily L. RyonNeha Goel Health Services Research and Global Oncology 25 September 2020 Pages: 1929 - 1936
ASO Author Reflections: Access to Care and Screening Inequities for Patients At Risk for Hepatocellular Carcinoma Joshua P. KronenfeldNeha Goel ASO Author Reflections 24 September 2020 Pages: 1937 - 1938
Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Propensity Score Survival Analysis Supporting Use in Patients with High-Risk Disease Ovie UtuamaJennifer B. PermuthDaniel A. Anaya Global Health Services Research 07 January 2021 Pages: 1939 - 1949
Chemoembolization Versus Radioembolization for Neuroendocrine Liver Metastases: A Meta-analysis Comparing Clinical Outcomes Lisa NgoAhmed ElnahlaMary Killackey Hepatobiliary Tumors 03 January 2021 Pages: 1950 - 1958
The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy Stéphanie TruantClio BailletFrançois-René Pruvot Hepatobiliary Tumors 24 August 2020 Pages: 1959 - 1969
Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy? Diamantis I. TsilimigrasJ. Madison HyerTimothy M. Pawlik Hepatobiliary Tumors 01 December 2020 Pages: 1970 - 1978
ASO Author Reflections: Tumor Burden in Intrahepatic Cholangiocarcinoma Diamantis I. TsilimigrasTimothy M. Pawlik ASO Author Reflections 03 January 2021 Pages: 1979 - 1980
ASO Visual Abstract: Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy? Diamantis I. TsilimigrasTimothy M. Pawlik ASO Visual Abstract 01 January 2021 Pages: 1981 - 1981
Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer John M. CreasyKristen M. CunananAmber L. Simpson Hepatobiliary Tumors 20 September 2020 Pages: 1982 - 1989
Oncologic Reappraisal of Bile Duct Resection for Middle-Third Cholangiocarcinoma Kosuke JikeiTomoki Ebatathe Nagoya Surgical Oncology Group Hepatobiliary Tumors 22 September 2020 Pages: 1990 - 1999
ASO Author Reflections: Bile Duct Resection—Is It Beneficial for Distal Cholangiocarcinoma? Tomoki EbataKosuke JikeiTakashi Mizuno ASO Author Reflections 22 October 2020 Pages: 2000 - 2000
Stratification of Postoperative Prognosis by Invasive Tumor Thickness in Perihilar Cholangiocarcinoma Mitsunobu ObaYoshitsugu NakanishiSatoshi Hirano Hepatobiliary Tumors 10 October 2020 Pages: 2001 - 2009
ASO Author Reflections: Can Invasive Tumor Thickness Stratify the Postoperative Prognosis of Perihilar Cholangiocarcinoma? Yoshitsugu NakanishiMitsunobu ObaSatoshi Hirano ASO Author Reflections 15 September 2020 Pages: 2010 - 2011
Safety and Oncological Benefit of Hepatopancreatoduodenectomy for Advanced Extrahepatic Cholangiocarcinoma with Horizontal Tumor Spread: Shinshu University Experience Akira ShimizuHiroaki MotoyamaYuji Soejima Hepatobiliary Tumors 12 October 2020 Pages: 2012 - 2025
ASO Author Reflections: Is Major Hepatopancreatoduodenectomy Beneficial for Patients with Advanced and Widespread Extrahepatic Cholangiocarcinoma? Akira ShimizuYuji Soejima ASO Author Reflections 21 October 2020 Pages: 2026 - 2027
Staged Double Hepatectomy, Double Total Vascular Exclusion, and Double Venous Reconstruction by Peritoneal Patches in One Patient with Colorectal Liver Metastases Safi DokmakBéatrice AussilhouOlivier Soubrane Hepatobiliary Tumors 23 September 2020 Pages: 2028 - 2029
Total Laparoscopic Resection of Hilar Cholangiocarcinoma Type 3b: Applying a Parachute Technique for Hepaticojejunostomy Robert SucherUwe ScheuermannDaniel Seehofer Hepatobiliary Tumors Open access 30 September 2020 Pages: 2030 - 2034
ASO Author Reflections: Hepatobiliary Surgeons are Spurred to Implement Totally Minimally Invasive Techniques for Perihilar Cholangiocarcinoma Surgery Robert SucherDaniel Seehofer ASO Author Reflections Open access 01 October 2020 Pages: 2035 - 2036
Landmark Trials in the Surgical Management of Mesothelioma Taylor KantorElliot Wakeam Thoracic Oncology 31 January 2021 Pages: 2037 - 2047
Clinicopathological Significance of Pathologic Complete Lymph Node Regression After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Po-Kuei HsuYi-Chen YehHan-Shui Hsu Thoracic Oncology 20 November 2020 Pages: 2048 - 2058
Comparison of Inflammation-Based Prognostic Scores Associated with the Prognostic Impact of Adenocarcinoma of Esophagogastric Junction and Upper Gastric Cancer Kensuke KudouYuichiro NakashimaMasaki Mori Thoracic Oncology 13 July 2020 Pages: 2059 - 2067
Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma Atsushi KagimotoYasuhiro TsutaniMorihito Okada Thoracic Oncology 18 September 2020 Pages: 2068 - 2075
ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection Atsushi KagimotoYasuhiro TsutaniMorihito Okada ASO Author Reflections 23 September 2020 Pages: 2076 - 2077
Tumor Maximum Area May Determine the Survival Outcomes of Patients with Thymic Epithelial Tumors Dong TianHaruhiko ShiiyaJun Nakajima Thoracic Oncology 19 September 2020 Pages: 2078 - 2085
ASO Author Reflections: Tumor Maximum Area is Better for Representing Tumor Size in Thymic Epithelial Tumors Dong TianHao-Ji YanJun Nakajima ASO Author Reflections 18 September 2020 Pages: 2086 - 2087
Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II–IIIA Lung Adenocarcinoma Donglai ChenQifeng DingYongsheng Zhang Thoracic Oncology 04 October 2020 Pages: 2088 - 2098
ASO Author Reflections: Old Song, New Sung—Extracapsular Extension in Lung Cancer in the Era of Eighth-Edition N Classification Donglai ChenQifeng DingYongbing Chen ASO Author Reflections 22 September 2020 Pages: 2099 - 2100
Verification of the Optimal Interval Before Esophagectomy After Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer Akiyuki WakitaSatoru MotoyamaYoshihiro Minamiya Thoracic Oncology 13 October 2020 Pages: 2101 - 2110
The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer Roberto A. Leon-FerreTina J. HiekenJudy C. Boughey Breast Oncology 23 January 2021 Pages: 2111 - 2119
The Landmark Series: Breast Conservation Trials (including oncoplastic breast surgery) Julie A. MargenthalerJill R. DietzAbhishek Chatterjee Breast Oncology 31 January 2021 Pages: 2120 - 2127
The Effect of Hospital Volume on Outcomes of Patients with Occult Breast Cancer Camille C. BaumruckerSamantha R. SpringDido Franceschi Breast Oncology 10 September 2020 Pages: 2128 - 2135
ASO Author Reflections: Hospital Volume, Cancer Outcomes and Access to Specialized Care Camille C. BaumruckerFrancis I. Macedo ASO Author Reflections 22 September 2020 Pages: 2136 - 2137
Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions Catherine UzanChafika MazouniStefan Michiels Breast Oncology 12 September 2020 Pages: 2138 - 2145
Treatment Patterns and Outcomes of Women with Breast Cancer and Supraclavicular Nodal Metastases Nina P. TamirisaYi RenRachel A. Greenup Breast Oncology 18 September 2020 Pages: 2146 - 2154
